RenovoRx, Inc. (RNXT)
Nasdaq: RNXT · Pharmaceutical Preparations · Mountain View, CA · filing with the SEC since 2013
Who owns RenovoRx, Inc.
As filed with the SECHolders of 5% or more
1
Orin Hirschman holds 9.8% of Common Stock, as its SCHEDULE 13G/A filed Apr 27, 2026 says.
Directors and officers
9
report now, of 14 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Orin Hirschman
SCHEDULE 13G/A · filed Apr 27, 2026 · Common Stock · 7.1% in Jan 30, 2026
AWM Investment Company, Inc.
SCHEDULE 13G/A · filed Nov 13, 2025 · Common Stock · reported falling below 5%, from 5.1% in Aug 14, 2025
What RNXT reports owning in othersstakes of 5% or more, and other ties
RenovoRx, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
13purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Oct 2, 2025 to Oct 2, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 2, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 17 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Agah Ramtin | Chief Medical Officer | 0 | $0 | 0 | 7 | $100,000 |
| Bagai Shaun | Chief Executive Officer | 0 | $0 | 0 | 3 | $0 |
| Voll Mark | Chief Financial Officer | 0 | $0 | 0 | 2 | $0 |
| Marton Laurence | director | 0 | $0 | 0 | 1 | $0 |